What You Should Know:
- Exai Bio and researchers at UCSF released data demonstrating that Exai’s novel, RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages and smallest tumor sizes.
- Earlier detection of breast cancer is crucial for optimal patient outcomes but cannot always be achieved based on symptoms or mammography.
Non-Invasive Blood-Based Platform Delivers Promising Data on Detecting Breast Cancer At It’s Earliest Stages
Exai Bio is a
Read More
Machine Learning in Healthcare | ML News, Analysis, Insights - HIT Consultant
Intel Labs & Penn Medicine Uses Privacy-Preserving AI to Identify Brain Tumors
What You Should Know:
- Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have completed a joint research study using federated learning – a distributed machine learning (ML) artificial intelligence (AI) approach – to help international healthcare and research institutions identify malignant brain tumors.
- The largest medical federated learning study to date with an unprecedented global dataset examined from 71 institutions across six
Read More
Driving Healthcare Operational Efficiency with IoT Sensing as a Service
Amid widespread staffing shortages across the healthcare sector, the need for IoT-enabled digital transformation in hospitals and patient care facilities is increasingly clear. For the first time since 2004, a lack of staffing has overtaken financial volatility as the No. 1 concern among healthcare CEOs in the American College of Healthcare Executives’ annual survey. Meanwhile, from canceled appointments to delayed surgeries, more than half of all U.S. patients report reductions in care quality
Read More
Lumen Raises $62M for Handheld Device to Measure Metabolic Health
What You Should Know:
- Lumen, the metabolic health company behind the first handheld device to measure your metabolism through the breath, today announced that it has raised $62M in a series B funding round led by Pitango Venture Capital.
- Participating investors include Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital, and Disruptive VC.
World’s Largest Platform For Measuring Metabolism To Expand Business Growth and Research
Lumen helps
Read More
The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank
Advanced medical research has brought us to the point where many serious conditions can potentially be treated and even cured - with people who have essentially faced a lifetime of being incapacitated finally able to conduct normal lives. Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. The latest example–and most expensive medication to date– is bluebird bio’s recently-approved $2.8 million gene therapy to treat a rare blood
Read More
HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others
Venture Capital, Private Equity Funding
Maven Clinic Secures $90M to Advance End-to-End Family Care Platform
Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere.
Curavit Raises $5M for Digital Therapeutics
Read More
HLTH22: COTA and Google Partner to Use NLP to Harness Unstructured Oncology Data
What You Should Know:
COTA, Inc., an oncology real-world data and analytics company announced a partnership with Google Cloud to bring clarity to unstructured oncology data through the latest advancements in machine learning and natural language processing.
- Many leading real-world data companies - including COTA - leverage clinicians to manually curate oncology real-world data. While this is a reliable and trusted near-term solution to overcoming the challenges associated with
Read More
5 Factors to Consider When Developing a Health Data Platform
The conversation around whether a healthcare startup should build a data platform or buy one isn’t anything new. In fact, this has been a debate since cloud-based technologies rose to popularity—we’re just now seeing more startups enter the space and opt to build their platforms internally.
Startups choose to build their data platforms for several compelling reasons. For example, it could give them greater control over their data security and architecture or they feel they know their data
Read More
Why Data Transparency Is the Most Important Metric for Healthcare Providers Right Now
Healthcare providers all over the world are battling with how to take patient information and patient care digital. How can we use the tools and technology at our fingertips to make treating patients easier and more effective, rather than more complicated? Converting data into useful information will be the key to making this transition successful.
Data is the currency, language, form, and function of digital transformation in healthcare. Having an easily accessible data warehouse and
Read More
ConcertAI CEO Talks COVID-19 & The De-Risking of Technology to Keep Trials Moving
Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was a shock for sponsors and providers. Sudden disruptions on that scale rarely hit multiple players in an ecosystem at the same time. But that’s exactly what happened at the intersection of clinical care and clinical development during the pandemic. Researchers and clinicians were forced to change how they operated trials, and
Read More
